American Healthcare REIT (NYSE:AHR) Reaches New 12-Month High After Analyst Upgrade

American Healthcare REIT, Inc. (NYSE:AHR) reached a new 52-week high during trading on Monday after Bank of America raised their price target on the stock from $27.00 to $31.00. Bank of America currently has a buy rating on the stock. American Healthcare REIT traded as high as $26.42 and last traded at $26.36, with a volume of 70605 shares changing hands. The stock had previously closed at $25.68.

Other analysts have also issued research reports about the company. Morgan Stanley increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. JMP Securities increased their price target on American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a report on Friday, September 20th. Truist Financial increased their price target on American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a report on Friday, September 20th. Finally, KeyCorp increased their price target on American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, September 16th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

Institutional Trading of American Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the business. Kiely Wealth Advisory Group Inc. purchased a new stake in American Healthcare REIT in the second quarter worth $30,000. Amalgamated Bank bought a new position in shares of American Healthcare REIT during the 2nd quarter worth $33,000. Semmax Financial Advisors Inc. bought a new position in shares of American Healthcare REIT during the 2nd quarter worth $45,000. CWM LLC bought a new position in shares of American Healthcare REIT during the 2nd quarter worth $58,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of American Healthcare REIT during the 2nd quarter worth $110,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.29 and a current ratio of 0.29. The business has a 50-day moving average price of $19.82 and a 200-day moving average price of $16.26.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.28). American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $506.55 million. American Healthcare REIT’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, equities analysts expect that American Healthcare REIT, Inc. will post 1.28 EPS for the current year.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, September 20th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 3.82%. The ex-dividend date of this dividend is Friday, September 20th.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.